Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab for Rhinovirus-Induced Asthma Exacerbations
NCT02388997Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Feb 2013
- Primary completion
- May 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of omalizumab in asthma, sponsored by University of Virginia. Started Feb 2013; status: completed.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02388997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388997.